MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, IRWD has $434,566K in assets. $220,471K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
140.62%
Quick Ratio
140.62%
Cash Ratio
93.30%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Accounts receivable, net
    • Deferred tax assets
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Revolving credit facility
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
220,471 215,456 140,407 92,852
Accounts receivable, net
105,842 46,745 120,370 86,172
Prepaid expenses and other current assets
5,979 11,977 13,066 12,729
Total current assets
332,292 274,178 273,843 191,753
Property and equipment, net
3,166 3,408 3,666 3,929
Operating lease right-of-use assets
8,896 9,340 9,775 10,201
Intangible assets, net
1,838 2,040 2,247 2,453
Deferred tax assets
84,237 103,433 101,687 129,459
Other assets
4,137 4,502 4,844 5,151
Total assets
434,566 396,901 396,062 342,946
Accounts payable
3,237 2,898 1,613 1,389
Accrued research and development costs
2,044 3,149 3,528 4,551
Accrued expenses and other current liabilities
27,903 33,239 34,620 24,033
Current portion of operating lease liabilities
3,268 3,252 3,236 3,220
Current portion of convertible senior notes
199,855 199,680 199,506 199,332
Total current liabilities
236,307 242,218 242,503 232,525
Operating lease obligations, net of current portion
9,233 9,870 10,498 11,117
Revolving credit facility
385,000 385,000 385,000 385,000
Other liabilities
21,170 21,648 22,218 22,466
Class a common stock, 0.001 par value, 500,000,000 shares authorized 164,613,406 shares issued and outstanding as of march 31, 2026 and 163,058,316 shares issued and outstanding as of december 31, 2025
165 163 163 162
Additional paid-in capital
1,416,431 1,412,780 1,408,836 1,405,224
Accumulated deficit
-1,632,945 -1,673,718 -1,671,442 -1,711,522
Accumulated other comprehensive loss
-795 -1,060 -1,714 -2,026
Total stockholders' deficit
-217,144 -261,835 -264,157 -308,162
Total liabilities and stockholders' deficit
434,566 396,901 396,062 342,946
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$220,471K Accounts receivable, net$105,842K Prepaid expenses andother current assets$5,979K Total current assets$332,292K Deferred tax assets$84,237K Operating leaseright-of-use assets$8,896K Other assets$4,137K Property and equipment,net$3,166K Intangible assets, net$1,838K Total assets$434,566K Accumulated deficit-$1,632,945K Accumulated othercomprehensive loss-$795K Total liabilities andstockholders' deficit$434,566K Total stockholders'deficit-$217,144K Additional paid-in capital$1,416,431K Class a common stock,0.001 par value,...$165K Revolving credit facility$385,000K Total currentliabilities$236,307K Other liabilities$21,170K Operating leaseobligations, net of current...$9,233K Current portion ofconvertible senior notes$199,855K Accrued expenses andother current...$27,903K Current portion ofoperating lease...$3,268K Accounts payable$3,237K Accrued research anddevelopment costs$2,044K

IRONWOOD PHARMACEUTICALS INC (IRWD)

IRONWOOD PHARMACEUTICALS INC (IRWD)